Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Archives of Cardiovascular Diseases

• Publication date

  2011-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.acvd.2010.11.013PMID 21497307
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

  2010cited by this paper
• The Bypass Angioplasty Revascularization Investigation 2 Diabetes Randomized Trial of Different Treatment Strategies in Type 2 Diabetes Mellitus With Stable Ischemic Heart Disease: Impact of Treatment Strategy on Cardiac Mortality and Myocardial Infarction

  2009cited by this paper
• Unrecognized Non-Q-Wave Myocardial Infarction: Prevalence and Prognostic Significance in Patients with Suspected Coronary Disease

  2009influential reference
• Incidence and Prognostic Implication of Unrecognized Myocardial Scar Characterized by Cardiac Magnetic Resonance in Diabetic Patients Without Clinical Evidence of Myocardial Infarction

  2008cited by this paper
• The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes

  2008cited by this paper
• Unrecognized Myocardial Infarction in Relation to Risk of Dementia and Cerebral Small Vessel Disease

  2008cited by this paper
• [Unrecognized myocardial infarction].

  2007cited by this paper
• The prevalence and prognosis of unrecognized myocardial infarction and silent myocardial ischemia in patients undergoing major vascular surgery

  2007influential reference
• The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study.

  2007cited by this paper
• Impact of Unrecognized Myocardial Scar Detected by Cardiac Magnetic Resonance Imaging on Event-Free Survival in Patients Presenting With Signs or Symptoms of Coronary Artery Disease

  2006influential reference
• Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study.

  2006cited by this paper
• Comparison of prevalence of unrecognized myocardial infarction and of silent myocardial ischemia detected by a treadmill exercise sestamibi stress test in patients with versus without diabetes mellitus.

  2006influential reference
• Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

  2005cited by this paper
• Echocardiographic characteristics of electrocardiographically unrecognized myocardial infarctions in a community population.

  2005cited by this paper
• Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled tri

  2005cited by this paper
• Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

  2005influential reference
• Which parameters on magnetic resonance imaging determine Q waves on the electrocardiogram?

  2005cited by this paper
• PROactive Study: PROspective pioglitAzone Clinical Trial In macroVascular Events

  2005cited by this paper
• Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintigraphy?

  2004cited by this paper
• Silent myocardial infarction and its prognosis in a community-based cohort of Type 2 diabetic patients: the Fremantle Diabetes Study

  2004influential reference
• Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients.

  2004cited by this paper
• Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

  2004cited by this paper
• Occurrence of unrecognized myocardial infarction in subjects aged 45 to 65 years (the ARIC study).

  2002cited by this paper
• Unrecognized Myocardial Infarction

  2001cited by this paper
• The Incidence of Unrecognized Myocardial Infarction in Women with Coronary Heart Disease

  2001cited by this paper
• The natural history of prevalent ischaemic heart disease in middle-aged men.

  2000cited by this paper
• Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly.

  2000influential reference
• Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

  1998cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• Incidence and prevalence of recognised and unrecognised myocardial infarction in women. The Reykjavik Study.

  1998cited by this paper
• Silent myocardial ischaemia and left ventricle hypertrophy in diabetic patients.

  1997cited by this paper
• Unrecognized Myocardial Infarction: Epidemiology, Clinical Characteristics, and the Prognostic Role of Angina Pectoris: The Reykjavik Study

  1995influential reference
• Asymptomatic coronary heart disease detected on epidemiological survey of urban population of Delhi.

  1992cited by this paper
• Metoprolol Versus Thiazide Diuretics in Hypertension Morbidity Results From the MAPHY Study

  1991cited by this paper
• Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: The Bronx Aging Study.

  1990influential reference
• Silent myocardial ischemia and infarction in diabetics with peripheral vascular disease: assessment by dipyridamole thallium-201 scintigraphy.

  1990cited by this paper
• Incidence, precursors and prognosis of unrecognized myocardial infarction.

  1990cited by this paper
• [Silent myocardial ischemia].

  1990cited by this paper
• The incidence and prognosis of unrecognized myocardial infarction in the Honolulu, Hawaii, Heart Program.

  1989cited by this paper
• Silent myocardial ischemia.

  1988cited by this paper
• Coronary heart disease in the Medical Research Council trial of treatment of mild hypertension. Medical Research Council Working Party on Mild Hypertension.

  1988cited by this paper
• [Electrocardiographic findings in 746 hypertensive patients enrolled in the Italian section of the International Prospective Primary Prevention Study in Hypertension (IPPPSH-Italy)].

  1988influential reference
• Unrecognized myocardial infarction: experience in the multiple risk factor intervention trial (MRFIT)

  1987cited by this paper
• Silent myocardial infarction and diabetic cardiovascular autonomic neuropathy.

  1986cited by this paper
• The Minnesota code manual of electrocardiographic findings : standards and procedures for measurement and classification

  1982cited by this paper
• The Electrocardiogram in Population Studies: A Classification System

  1960cited by this paper

• Ischemic Stroke as an Initial Manifestation of Silent, Evolved Myocardial Infarction: A Case Report

  2026cites this paper
• Interplay between Renal Dysfunction and Cardiovascular Complications: A Focus on Myocardial Infarction and Dietary Approaches

  2025cites this paper
• A Tale of Two Classes: Adapting Supervised Contrastive Learning to Binary Imbalanced Datasets

  2025cites this paper
• Macrophage Membrane-Coated Nanocarriers in Myocardial Infarction: A Paradigm Shift in Targeted Cardiac Therapy

  2025cites this paper
• Electrocardiographic criteria for silent myocardial infarction: Impact of different definitions on detection rates and prognostic significance in the atherosclerosis risk in communities (ARIC) study: A comparison with evolving bundle branch blocks.

  2025cites this paper
• Myocardial Ischaemic Syndromes in Chronic Kidney Disease: Risky Pathways from Non-Acute to Acute Events.

  2025cites this paper
• Complications cardiaques du patient diabétique (maladie coronaire, cardiomyopathie, neuropathie autonome cardiovasculaire) : dépistage

  2025cites this paper
• Silent Myocardial Infarction and Risk of Stroke Recurrence: A Post Hoc Analysis of the IRIS Trial

  2025cites this paper
• Long-term prognosis of unrecognized myocardial infarction in women and men from the general population: the Rotterdam Study.

  2025cites this paper
• An Atypical Presentation of ST-Segment Elevation Myocardial Infarction in a 30-Year-Old Male Patient: A Case Report

  2025cites this paper
• Silent ST-Segment Elevation Myocardial Infarction in a Patient Discovered via Telemetry Monitoring: A Case Report

  2025cites this paper
• Engineering mammalian cells for detection and treatment of cardiac injury

  2025cites this paper
• Cost-effectiveness of continuous real-time intracardiac recurrent event detection and alerting in high-risk acute coronary syndrome patients

  2025cites this paper
• Risk of Cardiovascular Disease With Co‐Occurring Covert Brain Infarction and Unrecognized Myocardial Infarction

  2025cites this paper
• Portable ECG Monitoring System for Early Detection of Cardiovascular Abnormalities

  2025cites this paper
• Myocardial Infarction and Traditional Cardiovascular Risk Factors in Older Patients in Primary Care

  2025cites this paper
• Optimized deep convolutional neural network with a long short-term memory framework for automated myocardial infraction detection in electrocardiogram images using Grey Wolf Optimizer

  2025cites this paper
• Infarto do Miocárdio e Fatores de Risco Cardiovascular Tradicionais em Idosos na Atenção Primária

  2025cites this paper
• Computational investigation of the effect of pre-existing silent myocardial infarction on acute myocardial infarction

  2025cites this paper
• The Effect of an mHealth Self-Monitoring Intervention (MI-BP) on Blood Pressure Among Black Individuals With Uncontrolled Hypertension: Randomized Controlled Trial

  2024cites this paper
• Silent Myocardial Ischemia: From Pathophysiology to Diagnosis and Treatment

  2024influential citation
• Effect of statin use for the primary prevention of cardiovascular disease among older adults: A cautionary tale concerning target trials emulation.

  2024cites this paper
• Association of relative hand grip strength with myocardial infarction and angina pectoris in the Korean population: a large-scale cross-sectional study

  2024influential citation
• An SNN-Inspired Area- and Power-Efficient VLSI Architecture of Myocardial Infarction Classifier for Wearable Devices

  2024cites this paper
• Burden of risk factors in women and men with unrecognized myocardial infarction: a systematic review and meta-analysis

  2024cites this paper
• Association between Blood Lead Levels and Silent Myocardial Infarction in the General Population

  2024cites this paper
• Sex and ethnic differences in unrecognized myocardial infarctions: Observations on recognition and preventive therapies from the multiethnic population-based HELIUS cohort

  2024cites this paper
• Acupuncture influences multiple diseases by regulating gut microbiota

  2024cites this paper
• Faut-il dépister l’ischémie myocardique silencieuse des patients diabétiques ?

  2024cites this paper
• Longitudinal blood glucose level and increased silent myocardial infarction: a pooled analysis of four cohort studies

  2024cites this paper
• Edge-AI on Wearable Devices: Myocardial Infarction Detection with Spectrogram and 1D-CNN

  2024cites this paper
• Management of Hypertension in Patients with Type 2 Diabetes Mellitus: Indian Guideline 2024 by Association of Physicians of India and Indian College of Physicians.

  2024cites this paper
• Prevalence of classic and non-classic pain sites of coronary artery disease: a cross-sectional study

  2024cites this paper
• An Electrochemical Biosensor for the Detection of Pulmonary Embolism and Myocardial Infarction

  2024cites this paper
• The unexpected silent manifestation of myocardial infarctions in ischemic heart failure patients: Insights from a case-control study

  2024cites this paper
• Physiotherapy Screening for Referral of a Patient with Patent Foramen Ovale Presenting with Neck Pain as Primary Complaint: A Case Report

  2023cites this paper
• Screening Test for Evaluation of Cardiovascular Disease in Patients with Diabetes

  2023cites this paper
• Increased Epicardial Adipose Tissue and Heart Characteristics Are Correlated with BMI and Predict Silent Myocardial Infarction in Sudden Cardiac Death Subjects: An Autopsy Study

  2023cites this paper
• Silent myocardial infarction fatty scars detected by coronary calcium score CT scan in diabetic patients without history of coronary heart disease

  2023influential citation
• Myocardial Infarction as a Consequence of Mitochondrial Dysfunction

  2023cites this paper
• Evaluation of cardiopreventive effects of Ximenia americana (Linn.) and Pappea capensis (Eckl. and Zeyh.) leaf aqueous extracts in rat models with myocardial infarction

  2023cites this paper
• Disease incidence and not case fatality drives the rural disadvantage in myocardial-infarction-related mortality in Germany.

  2023cites this paper
• Myorcadial Infarction Classification with 15 Lead Electrocardiogram (ECG) Signal using Hybrid Convolutional Neural Network (CNN) and Bidirectional Long Short-Term Memory (BILSTM)

  2023cites this paper
• Performance of the 2019 ESC/EASD guideline strategy for the screening of silent coronary artery disease in patients with diabetes

  2023cites this paper
• Renal Embolism Associated with Foramen Ovale Coexisting Acute Pulmonary Embolism

  2023cites this paper
• Associations of cardiovascular and diabetes-related risk factors with myocardial perfusion reserve assessed by 201Tl/99mTc-tetrofosmin single-photon emission computed tomography in patients with diabetes mellitus and stable coronary artery disease

  2023cites this paper
• Comparison of in Hospital Complications and Mortality between Diabetic and Non-Diabetic Patients Admitted with Acute Anterior MI

  2023cites this paper
• A Wearable LSTM Autoencoder-based ECG Detection System to Predict Myocardial Infarction

  2023cites this paper
• Best of Both Worlds: Multimodal Contrastive Learning with Tabular and Imaging Data

  2023cites this paper
• Evaluation of Oxidative Stress in Iraqi Male Patients with Myocardial Infarction and Type 2 Diabetes Mellitus

  2023cites this paper
• Relation of glycemic status with unrecognized MI and the subsequent risk of mortality: The Jackson Heart Study

  2022cites this paper
• Assessing myocardial infarction severity from the urban environment perspective in Wuhan, China.

  2022cites this paper
• Synergistic impacts of Montelukast and Klotho against doxorubicin-induced cardiac toxicity in Rats.

  2022cites this paper
• Myocardial Infarction Discharge Planning: Nurses, Approaches

  2022cites this paper
• Cardio protective activity of Sargassum wightii on isoproterenol induced myocardial stress in rats

  2022cites this paper
• Identification of Potential Diagnostic Biomarkers From Circulating Cells During the Course of Sleep Deprivation-Related Myocardial Infarction Based on Bioinformatics Analyses

  2022cites this paper
• Deep Learning for Detecting and Locating Myocardial Infarction by Electrocardiogram: A Literature Review

  2022cites this paper
• Examination of New Electrocardiographic Repolarization Markers in Diabetic Patients with Noncritical Coronary Artery Disease

  2022cites this paper
• Rapid and label-free detection of the troponin in human serum by a TiN-based extended-gate field-effect transistor biosensor.

  2022cites this paper
• Yield of Echocardiography in Ischemic Stroke and Patients With Transient Ischemic Attack With Established Indications for Long‐Term Direct Oral Anticoagulant Therapy: A Cross‐Sectional Diagnostic Cohort Study

  2022cites this paper
• KUJDESI INFERMIEROR TEK PACIENTET ME INFARKT TË MIOKARDIT

  2021cites this paper
• Silent Myocardial Infarction and Acute Multiorgan Failure in a COVID-19 Patient: A Case Report

  2021cites this paper
• The Antihypertensive Effects and Potential Molecular Mechanism of Microalgal Angiotensin I-Converting Enzyme Inhibitor-Like Peptides: A Mini Review

  2021cites this paper
• Higher prevalence of incidental findings identified upon coronary calcium score assessment in type 2 and type 3 diabetes versus type 1 diabetes

  2021cites this paper
• Prevalence of asymptomatic or “silent” myocardial ischemia in diabetic patients: Protocol for a systematic review and meta-analysis

  2021cites this paper
• Silent coronary artery disease in type 2 diabetes: a narrative review on epidemiology, risk factors, and clinical studies

  2021influential citation
• An injectable hydrogel to reverse the adverse microenvironment of diabetic infarcted heart

  2021cites this paper
• Cardiovascular disease prevention and therapy in women with Type 2 diabetes.

  2021cites this paper
• Forced Degradation Study for Simultaneous Quantification of Aspirin and Omeprazole in Pharmaceutical Dosage form by RP-HPLC

  2021cites this paper
• Investigating the Association of IL-1beta IL-8 & IL 11 with Commonly used Cardiovascular Biomarkers (CK-MB & Troponin) in Patients with Myocardial Infarction (MI)

  2021cites this paper
• The utility of silent myocardial infarction on electrocardiogram as an ASCVD risk enhancer for primary prevention: The multi-ethnic study of atherosclerosis.

  2021cites this paper
• Endocrinology and Systemic Diseases

  2020cites this paper
• Guía ESC 2019 sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes (EASD)

  2020cites this paper
• Prevalence of ECG abnormalities in people with type 2 diabetes: The Hoorn Diabetes Care System cohort.

  2020cites this paper
• DNA methylation-based biomarkers of age acceleration and all-cause death, myocardial infarction, stroke, and cancer in two cohorts: The NAS, and KORA F4

  2020cites this paper
• Risk stratification and screening for coronary artery disease in asymptomatic patients with diabetes mellitus.

  2020cites this paper
• Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008–2011

  2020influential citation
• Risk stratification and screening for coronary artery disease in asymptomatic patients with diabetes mellitus: Position paper of the French Society of Cardiology and the French-speaking Society of Diabetology.

  2020influential citation
• Association of Recognized and Unrecognized Myocardial Infarction With Depressive and Anxiety Disorders in 125,988 Individuals

  2020cites this paper
• Ischemia/Reperfusion Injury: Pathophysiology, Current Clinical Management, and Potential Preventive Approaches

  2020cites this paper
• Comportamiento del infarto agudo de miocardio en una unidad de cuidado intensivo de una ciudad intermedia durante un año.

  2020cites this paper
• Study of high-sensitivity C-Reactive protein levels in subjects with type 2 diabetes mellitus

  2020cites this paper
• EVALUATION OF ANGIOTENSIN CONVERTING ENZYME GENE POLYMORPHISM AS A RISK FOR MYOCARDIAL INFARCTION WITH / WITHOUT TYPE 2 DIABETIC IRAQI PATIENTS

  2020cites this paper
• Impact of Endocrine Disorders on the Heart

  2020cites this paper
• Non-alcoholic fatty liver disease is not independent risk factor for cardiovascular disease event: A cohort study

  2020cites this paper
• Diabetes and the Cardiovascular System

  2020cites this paper
• Sudden Death from Ischemic Heart Disease While Driving: Cardiac Pathology, Clinical Characteristics, and Countermeasures

  2020cites this paper
• Behavior of acute myocardial infarctions in an intensive care unit of a medium-size city over a one-year span

  2020cites this paper
• Sex‐Based Differences in Unrecognized Myocardial Infarction

  2020cites this paper
• High Serum Aspartate Aminotransferase, Underweight, and Weight Loss in Older People: Results of the KITCHEN-4

  2020cites this paper
• Influence of sex on the incidence of potential coronary artery disease and long-term outcomes in asymptomatic patients with diabetes mellitus

  2020cites this paper
• Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk.

  2020cites this paper
• Mesenchymal Stem Cells and Cardiovascular Diseases

  2020cites this paper
• Myocardial Infarction

  2020cites this paper
• Association of Recognized and Unrecognized Myocardial Infarction With Depressive and Anxiety Disorders in 125,988 Individuals: A Report of the Lifelines Cohort Study

  2020influential citation
• Chronic Infarcts and Mimickers of Infarcts.

  2019cites this paper
• Time to reperfusion in high-risk patients with myocardial infarction undergoing primary percutaneous coronary intervention.

  2019cites this paper
• Impact of the Location of ST-T Abnormalities Accompanying Minor Q-Waves on the Definition of Prior Myocardial Infarction.

  2019cites this paper
• Electrocardiographic definition of silent myocardial infarction in population studies: A call to standardize the standards.

  2019cites this paper
• Kidney stone history and adverse outcomes after percutaneous coronary intervention.

  2019cites this paper